Selected research
Market Structure
Global EPA and DHA Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global EPA and DHA market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.
The US & Canada market for EPA and DHA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for EPA and DHA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for EPA and DHA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for EPA and DHA is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of EPA and DHA include DSM, Tianhecheng, Lonza, Yidie, Stepan, Runke, Novotech Nutraceuticals, Kingdomway and Fuxing, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
This report provides an overview of the global EPA and DHA market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of EPA and DHA and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents EPA and DHA sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the EPA and DHA market size, projected growth trends, production technologies, key applications, and end-use industries.
EPA and DHA Segment by Company
DSM
Tianhecheng
Lonza
Yidie
Stepan
Runke
Novotech Nutraceuticals
Kingdomway
Fuxing
Cabio
Arjuna Natural
EPA and DHA Segment by Type
EPA
DHA
EPA and DHA Segment by Application
Infant Formula
Food and Beverage
Dietary Supplements
Others
EPA and DHA Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global EPA and DHA market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of EPA and DHA and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of EPA and DHA.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the EPA and DHA market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of EPA and DHA manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of EPA and DHA in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of EPA and DHA in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- EPA
- DHA
Applications
- Infant Formula
- Food and Beverage
- Dietary Supplements
- Others
Companies covered
- DSM
- Tianhecheng
- Lonza
- Yidie
- Stepan
- Runke
- Novotech Nutraceuticals
- Kingdomway
- Fuxing
- Cabio
- Arjuna Natural
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global EPA and DHA Market Size, 2021 VS 2025 VS 2032
- 1.3 Global EPA and DHA Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global EPA and DHA Sales Estimates and Forecasts (2021-2032)
- 1.5 Global EPA and DHA Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global EPA and DHA Market Dynamics
- 2.1 EPA and DHA Industry Trends
- 2.2 EPA and DHA Industry Drivers
- 2.3 EPA and DHA Industry Opportunities and Challenges
- 2.4 EPA and DHA Industry Restraints
3 EPA and DHA Market by Manufacturers
- 3.1 Global EPA and DHA Revenue by Manufacturers (2021-2026)
- 3.2 Global EPA and DHA Sales by Manufacturers (2021-2026)
- 3.3 Global EPA and DHA Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global EPA and DHA Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global EPA and DHA Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global EPA and DHA Manufacturers, Product Type & Application
- 3.7 Global EPA and DHA Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global EPA and DHA Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 EPA and DHA Players Market Share by Revenue in 2025
- 3.8.3 2025 EPA and DHA Tier 1, Tier 2, and Tier 3
4 EPA and DHA Market by Type
- 4.1 EPA and DHA Type Introduction
- 4.1.1 EPA
- 4.1.2 DHA
- 4.2 Global EPA and DHA Sales by Type
- 4.2.1 Global EPA and DHA Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global EPA and DHA Sales by Type (2021-2032)
- 4.2.3 Global EPA and DHA Sales Market Share by Type (2021-2032)
- 4.3 Global EPA and DHA Revenue by Type
- 4.3.1 Global EPA and DHA Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global EPA and DHA Revenue by Type (2021-2032)
- 4.3.3 Global EPA and DHA Revenue Market Share by Type (2021-2032)
5 EPA and DHA Market by Application
- 5.1 EPA and DHA Application Introduction
- 5.1.1 Infant Formula
- 5.1.2 Food and Beverage
- 5.1.3 Dietary Supplements
- 5.1.4 Others
- 5.2 Global EPA and DHA Sales by Application
- 5.2.1 Global EPA and DHA Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global EPA and DHA Sales by Application (2021-2032)
- 5.2.3 Global EPA and DHA Sales Market Share by Application (2021-2032)
- 5.3 Global EPA and DHA Revenue by Application
- 5.3.1 Global EPA and DHA Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global EPA and DHA Revenue by Application (2021-2032)
- 5.3.3 Global EPA and DHA Revenue Market Share by Application (2021-2032)
6 Global EPA and DHA Sales by Region
- 6.1 Global EPA and DHA Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global EPA and DHA Sales by Region (2021-2032)
- 6.2.1 Global EPA and DHA Sales by Region (2021-2026)
- 6.2.2 Global EPA and DHA Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America EPA and DHA Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America EPA and DHA Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe EPA and DHA Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe EPA and DHA Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific EPA and DHA Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific EPA and DHA Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa EPA and DHA Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa EPA and DHA Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global EPA and DHA Revenue by Region
- 7.1 Global EPA and DHA Revenue by Region
- 7.1.1 Global EPA and DHA Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global EPA and DHA Revenue by Region (2021-2026)
- 7.1.3 Global EPA and DHA Revenue by Region (2027-2032)
- 7.1.4 Global EPA and DHA Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America EPA and DHA Revenue (2021-2032)
- 7.2.2 North America EPA and DHA Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe EPA and DHA Revenue (2021-2032)
- 7.3.2 Europe EPA and DHA Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific EPA and DHA Revenue (2021-2032)
- 7.4.2 Asia-Pacific EPA and DHA Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa EPA and DHA Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa EPA and DHA Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 DSM
- 8.1.1 DSM Company Information
- 8.1.2 DSM Business Overview
- 8.1.3 DSM EPA and DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 DSM EPA and DHA Product Portfolio
- 8.1.5 DSM Recent Developments
- 8.2 Tianhecheng
- 8.2.1 Tianhecheng Company Information
- 8.2.2 Tianhecheng Business Overview
- 8.2.3 Tianhecheng EPA and DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 Tianhecheng EPA and DHA Product Portfolio
- 8.2.5 Tianhecheng Recent Developments
- 8.3 Lonza
- 8.3.1 Lonza Company Information
- 8.3.2 Lonza Business Overview
- 8.3.3 Lonza EPA and DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Lonza EPA and DHA Product Portfolio
- 8.3.5 Lonza Recent Developments
- 8.4 Yidie
- 8.4.1 Yidie Company Information
- 8.4.2 Yidie Business Overview
- 8.4.3 Yidie EPA and DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Yidie EPA and DHA Product Portfolio
- 8.4.5 Yidie Recent Developments
- 8.5 Stepan
- 8.5.1 Stepan Company Information
- 8.5.2 Stepan Business Overview
- 8.5.3 Stepan EPA and DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Stepan EPA and DHA Product Portfolio
- 8.5.5 Stepan Recent Developments
- 8.6 Runke
- 8.6.1 Runke Company Information
- 8.6.2 Runke Business Overview
- 8.6.3 Runke EPA and DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Runke EPA and DHA Product Portfolio
- 8.6.5 Runke Recent Developments
- 8.7 Novotech Nutraceuticals
- 8.7.1 Novotech Nutraceuticals Company Information
- 8.7.2 Novotech Nutraceuticals Business Overview
- 8.7.3 Novotech Nutraceuticals EPA and DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Novotech Nutraceuticals EPA and DHA Product Portfolio
- 8.7.5 Novotech Nutraceuticals Recent Developments
- 8.8 Kingdomway
- 8.8.1 Kingdomway Company Information
- 8.8.2 Kingdomway Business Overview
- 8.8.3 Kingdomway EPA and DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Kingdomway EPA and DHA Product Portfolio
- 8.8.5 Kingdomway Recent Developments
- 8.9 Fuxing
- 8.9.1 Fuxing Company Information
- 8.9.2 Fuxing Business Overview
- 8.9.3 Fuxing EPA and DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 Fuxing EPA and DHA Product Portfolio
- 8.9.5 Fuxing Recent Developments
- 8.10 Cabio
- 8.10.1 Cabio Company Information
- 8.10.2 Cabio Business Overview
- 8.10.3 Cabio EPA and DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.10.4 Cabio EPA and DHA Product Portfolio
- 8.10.5 Cabio Recent Developments
- 8.11 Arjuna Natural
- 8.11.1 Arjuna Natural Company Information
- 8.11.2 Arjuna Natural Business Overview
- 8.11.3 Arjuna Natural EPA and DHA Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.11.4 Arjuna Natural EPA and DHA Product Portfolio
- 8.11.5 Arjuna Natural Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 EPA and DHA Value Chain Analysis
- 9.1.1 EPA and DHA Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 EPA and DHA Production Mode & Process
- 9.2 EPA and DHA Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 EPA and DHA Distributors
- 9.2.3 EPA and DHA Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst